Publications by authors named "Daniel Lorand"

Claim this Profile
A
Artificial Intelligence-Based Disease Activity Monitoring to Personalized Neovascular Age-Related Macular Degeneration Treatment: A Feasibility Study.
Zufar Mulyukov, Pearse A Keane, Jayashree Sahni, Sandra Liakopoulos, Katja Hatz, Daniel Lorand

Ophthalmol Sci· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic response in the HAWK and HARRIER trials using deep learning in retinal fluid volume and compartment analysis.
Ursula Schmidt-Erfurth, Zufar Mulyukov, Bianca S Gerendas, Gregor S Reiter, Daniel Lorand

Eye (Lond)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does real-time artificial intelligence-based visual pathology enhancement of three-dimensional optical coherence tomography scans optimise treatment decision in patients with nAMD? Rationale and design of the RAZORBILL study.
Frank G Holz, Rodrigo Abreu-Gonzalez, Francesco Bandello, Renaud Duval, Louise O'Toole, Daniel Lorand

Br J Ophthalmol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A framework to guide dose & regimen strategy for clinical drug development.
Oliver Sander, Baldur Magnusson, Inga Ludwig, Astrid Jullion, Christophe Meille, Daniel Lorand

CPT Pharmacometrics Syst Pharmacol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robust ΔΔct estimate.
Arun Kumar, Daniel Lorand

Genomics· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A practical design for a dual-agent dose-escalation trial that incorporates pharmacokinetic data.
Amy Cotterill, Daniel Lorand, Jixian Wang, Thomas Jaki

Stat Med· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of various diuretic treatments on rosiglitazone-induced fluid retention.
Janaka Karalliedde, Robin Buckingham, Margaret Starkie, Daniel Lorand, Murray Stewart

J Am Soc Nephrol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis